Monthly Archives: September 2010

New technique unveiled for protecting donor organs that could double life of the graft, study finds

Scientists in the United Kingdom (UK) claim the have developed a new treatment, similar to paint, that has the potential of doubling the life of a donor kidney, the Australian Broadcasting Corporation News (ABC News) reported. On average a health transplanted kidney can survive for about 10 years; transplanted hearts usually fail even sooner; and [Sign in to read the full article...]

New warning signs may predict whether a kidney transplant will succeed—Mayo study

Kidney transplants that show a combination of fibrosis and inflammation after one year are at higher risk of long-term failure, according to researchers at the Mayo Clinic, Rochester, MN. To identify the abnormalities, physicians would have to perform routine biopsies on apparently normal kidney transplants—rather than waiting for problems to occur. “Even for some transplants [Sign in to read the full article...]

Adult stem cells show promise in treating age-related macular degeneration and retinitis pigmentosa

A research study is showing promise that adult stem cells within the retina can be chemically induced to regenerate photoreceptors and restore vision in people suffering from conditions such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP). The research, which is being conducted at the University of Nebraska Medical Center (UNMC), was done on [Sign in to read the full article...]

Briefcase-size power and monitoring device for patients with temporary heart being tested

Researchers at Virginia Commonwealth University Medical Center in Richmond are testing a briefcase-size power and monitoring device that allows patients with a temporary artificial heart to wait at home for a heart transplant. The new, portable device weights about 14 pounds and can be worn in a backpack or shoulder bag—so patients have more freedom [Sign in to read the full article...]

New devices for heart failure patients approved by the FDA

The US Food and Drug Administration (FDA) announced today that it has approved a new indication for three cardiac resynchronization therapy defibrillators (CRT-D) used to treat certain heart failure patients. The new use if for patient with an abnormality known as left bundle branch block, which occurs when there is delayed activation and contraction of [Sign in to read the full article...]